TheEdgeResearch
Home / Stocks / ACAI

Safeplus International Holdings Limited (ACAI)

OTC Healthcare Medical - Devices
$0.00 ▲ +0.00%
Market Cap
$25,384
Sector
Healthcare
Industry
Medical - Devices
Beta
-1.01
52-Wk Range
0.00003-0.001
CEO
Shaocheng Tang
Country
US
Currency
USD

Safeplus International Holdings Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Pittsford, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $25,384. On trailing twelve-month figures it carries a trailing P/E of -1.43, a net margin of 0.0%. Its beta of -1.01 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.43
Price / Sales
0.00
Price / Book
1.12
EV / EBITDA
0.49
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
3.63
Current ratio
0.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2002-01-02
Headquarters
Pittsford, NY, US
About Safeplus International Holdings Limited

Safeplus International Holdings Limited, headquartered in Pittsford, New York, and established in 1963, specializes in developing and bringing to market advanced technological solutions for the medical device sector. Formerly operating as Biophan Technologies, Inc. until its rebranding in September 2020, the company is currently looking for partners to help commercialize its extensive portfolio of patented innovations. These proprietary technologies include biothermal power supplies, pulsewidth modulation designed to significantly improve the functionality of pacemakers and neurostimulators, and patented breakthroughs in photonics and nanomaterials.

Comparable companies

Safeplus International Holdings Limited is most often compared with the following Healthcare names:

AHFDARBUBFHJGIBXIVMEDMDLMNICHPHCFFSPOISYSX
More research on ACAI
ACAI technical analysis ACAI TheEdge Score Compare against peers
Open full interactive analysis & DCF →